China National Pharmaceutical Group Corporation (Sinopharm) (600420.SH) recorded a net profit attributable to shareholders of 672 million yuan in the first half of the year, a year-on-year decrease of 6.46%.

Zh tng cijng APP xn, gu yo xin di (600420.SH) pl 2025 nin bn nin d yj kui bo, gngs shng bn nin yngy zng shur 48.78 y yun, tng b xijing 18.16%; gush y shng sh gngs gdng de jngl 6.72 y yun, tng b xijing 6.46%; gush y shng sh gngs gdng de kuch fi jngchngxng sny de jngl 6.37 y yun, tng b xijing 6.72%. Jbn mi g shuy 0.5011 yun. Zhtng Finance APP news, China National Pharmaceutical Group (600420.SH) disclosed its 2025 semi-annual performance report, with the company's total operating income in the first half of the year reaching 4.878 billion yuan, a year-on-year decrease of 18.16%; the net profit attributable to shareholders of the listed company was 672 million yuan, a year-on-year decrease of 6.46%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 637 million yuan, a year-on-year decrease of 6.72%. Basic earnings per share was 0.5011 yuan.